Back to search
FDAFDA · Food and drugs·Recall number Z-1270-2024

Synapse PACS - Version 7.2.000

Published March 13, 2024 · Recall initiated: January 10, 2024

Summary

FDA records medical device Class II recall Z-1270-2024, published March 13, 2024 and initiated January 10, 2024. Recalling firm: FUJIFILM Healthcare Americas Corporation; Status: Ongoing; Reported quantity: 19 Units (7 US, 12 OUS); Lot: Software Version: 7.2.000, UDI: (01)854904006008(10)0702000. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Measurements on a Secondary Capture 2D image, that does not have pixel spacing in the DICOM header, when combined with a Breast Tomo Series results in incorrect measurements.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
FUJIFILM Healthcare Americas Corporation
Distributor
Worldwide distribution - US Nationwide, including Puerto Rico and the countries of Australia, Belgium, Brazil, Canada, Colombia, Ecuador, France, Germany, India, Italy, Mexico, Namibia, Netherlands, Portugal, Qatar, Spain, Thailand, Turkey, UAE, United Kingdom.
Lot
Software Version: 7.2.000, UDI: (01)854904006008(10)0702000
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Synapse PACS - Version 7.2.000 recalled?

Yes. FDA published recall Z-1270-2024 on March 13, 2024. Reported hazard: Measurements on a Secondary Capture 2D image, that does not have pixel spacing in the DICOM header, when combined with a Breast Tomo Series results in incorrect measurements.

What should I do if I have this product?

Voluntary: Firm initiated · Letter